1. Home
  2. DLPN vs EVAX Comparison

DLPN vs EVAX Comparison

Compare DLPN & EVAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DLPN
  • EVAX
  • Stock Information
  • Founded
  • DLPN 1996
  • EVAX 2008
  • Country
  • DLPN United States
  • EVAX Denmark
  • Employees
  • DLPN N/A
  • EVAX N/A
  • Industry
  • DLPN Other Consumer Services
  • EVAX Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • DLPN Consumer Discretionary
  • EVAX Health Care
  • Exchange
  • DLPN Nasdaq
  • EVAX Nasdaq
  • Market Cap
  • DLPN 16.9M
  • EVAX 17.8M
  • IPO Year
  • DLPN N/A
  • EVAX 2021
  • Fundamental
  • Price
  • DLPN $1.55
  • EVAX $6.44
  • Analyst Decision
  • DLPN Strong Buy
  • EVAX Strong Buy
  • Analyst Count
  • DLPN 1
  • EVAX 2
  • Target Price
  • DLPN $5.00
  • EVAX $13.50
  • AVG Volume (30 Days)
  • DLPN 65.9K
  • EVAX 4.8M
  • Earning Date
  • DLPN 11-13-2025
  • EVAX 11-07-2025
  • Dividend Yield
  • DLPN N/A
  • EVAX N/A
  • EPS Growth
  • DLPN N/A
  • EVAX N/A
  • EPS
  • DLPN N/A
  • EVAX N/A
  • Revenue
  • DLPN $51,257,243.00
  • EVAX $3,176,000.00
  • Revenue This Year
  • DLPN $9.05
  • EVAX N/A
  • Revenue Next Year
  • DLPN $15.42
  • EVAX $425.50
  • P/E Ratio
  • DLPN N/A
  • EVAX N/A
  • Revenue Growth
  • DLPN 4.84
  • EVAX 1042.45
  • 52 Week Low
  • DLPN $0.75
  • EVAX $1.20
  • 52 Week High
  • DLPN $1.78
  • EVAX $15.50
  • Technical
  • Relative Strength Index (RSI)
  • DLPN 60.42
  • EVAX 53.50
  • Support Level
  • DLPN $1.35
  • EVAX $6.15
  • Resistance Level
  • DLPN $1.68
  • EVAX $12.15
  • Average True Range (ATR)
  • DLPN 0.13
  • EVAX 1.42
  • MACD
  • DLPN 0.00
  • EVAX 0.02
  • Stochastic Oscillator
  • DLPN 67.44
  • EVAX 27.67

About DLPN Dolphin Entertainment Inc.

Dolphin Entertainment Inc is an independent entertainment marketing and production company. It provides strategic marketing and publicity services to many of the top brands, both individual and corporate, in the motion picture, television, music, gaming, culinary, hospitality, and lifestyle industries. It operates in two reportable segments: Entertainment publicity and marketing and Content production. It generates the majority of its revenue from the Entertainment publicity and marketing segment which provides clients with diversified marketing services, including public relations, entertainment and hospitality content marketing, strategic marketing consulting, and content production of marketing materials.

About EVAX Evaxion Biotech

Evaxion AS is a techBio company based on its AI platform, AI-Immunology. Evaxion's proprietary and scalable AI prediction models harness the power of artificial intelligence to decode the human immune system and develop novel immunotherapies for cancer, bacterial diseases, and viral infections. Evaxion has developed a clinical-stage oncology pipeline of novel personalised vaccines and a preclinical infectious disease pipeline in bacterial and viral diseases with high unmet medical needs. The group is committed to transforming patients' lives by providing innovative and targeted treatment options.

Share on Social Networks: